The report published on the 5th October contains information on drug-related deaths for the year 2005 reported by Coroners in England & Wales and the Islands (Guernsey, Jersey and Isle of Man). Information on such deaths recorded by the Scottish Crime and Drug Enforcement Agency and the General Register Office for Northern Ireland is also given; these sources also indicate a decrease in 2005.
Opiates/opioids (i.e. heroin/morphine; methadone; other opiate/opioid analgesics), alone or in combination with other drugs, accounted for the majority of fatalities (70 per cent) in 2005. There was an increase of one per cent (to 49%) in the proportion of deaths involving heroin/morphine. The proportion of cases involving cocaine increased from 10% to 13%. A decrease of about two percentage points in the proportion of cases involving hypnotics/sedatives (i.e. diazepam) was observed. The proportions of deaths involving other illicit drugs remained stable.
Brighton & Hove recorded the highest annual drug-related death rate per 100,000 population (24.2), followed by Dumbarton (13.4); Blackpool & the Fylde (12.8); Isle of Man (11.3); East Lancashire (10.0); Liverpool (9.4); Southampton & New Forest (8.7); and Neath Port Talbot (8.2). Of these eight areas, only the Isle of Man showed a significant increase over 2004 (up from 1.6). Compared with 2004, the following areas reported a notable reduction in deaths amongst those aged 16 and over, than in the previous year: in Liverpool there were 57 deaths in 2004, which reduced to 34 in 2005; Jersey had a reduction from 9 in 2004 to 3 in 2005.
The following areas reported higher number of deaths among those aged 16 and over, than in the previous year: Torbay & South Devon reported an increase from 1 death in 2004 to 9 deaths in 2005; Ceredigion saw an increase from zero to 5; the number of deaths in Cheltenham rose from 2 in 2004 to 10 in 2005; in the Black Country the number doubled from 5 to 10 deaths; in Surrey there were 12 deaths in 2005, compared to 7 in 2004; Exeter & Greater Devon experienced an increase from 30 to 42 deaths.
In commenting on the above data, Professor Hamid Ghodse, Director of the International Centre for Drug Policy, St George’s, University of London, said: “The findings of this report indicate an overall decrease in drug-related deaths in the UK. This is excellent news and could well be the result of both the drug misuse monitoring and prevention initiatives promoted and carried out in the last few years. We hope that this trend will continue. However, following the rise in drug-related deaths in 2004, there is the need for continued vigilance and constant monitoring of the drug-related deaths situation to ensure that the trend continues to decline and lives are saved. I would like to thank the Department of Health for their support for this very important Programme”.
Professor Michael Farthing, Principal of St George’s Medical School and Pro-Vice- Chancellor for Medicine at the University of London, commented: “The mission of St George’s and its Centres of Excellence such as the ICDP is to promote — by excellence in teaching, clinical practice and research — the prevention, treatment and understanding of disease. Drug abuse and addiction contribute a great deal of misery to the lives of individuals, families and society as a whole. In order to prevent this phenomenon, it is of paramount importance to include the issue of tackling substance abuse in the education of the medical, nursing and caring professions as well as that of the public. The provision of informed analysis, such as that published today by the National Programme on Substance Abuse Deaths, assists these groups in the reduction of morbidity and mortality related to drugs".
Andrea Vazquez | alfa
Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign
Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
20.01.2017 | Awards Funding
20.01.2017 | Materials Sciences
20.01.2017 | Life Sciences